Targeting the IL-6 Pathway in Multiple Myeloma and its Implications in Cancer-Associated Gene Hypermethylation

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|5|473-479

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.5, 2011-09, pp. : 473-479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Gene therapy for Multiple Myeloma

By  

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 247-255

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signaling Pathways in Multiple Myeloma

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 407-413

Bentham Science Publishers

Access to resources Recommend Favorite